Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prime Medical Services was a leading provider of urological services and medical technology management in the United States. The company specialized in providing mobile and fixed-site lithotripsy services, which use shock waves to non-invasively break up kidney stones. In addition to its core lithotripsy business, Prime Medical offered treatments for benign prostatic hyperplasia (BPH) and prostate cancer, and managed several ambulatory surgery centers. The company was publicly traded on the NASDAQ under the symbol PMSI until its merger with Medstone International in 2005, which resulted in the formation of HealthTronics. This merger created one of the largest urological service providers in the country, offering a comprehensive suite of clinical and technology solutions to hospitals and physicians.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prime Medical Services.